Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-28T18:10:28.087Z Has data issue: false hasContentIssue false

SHEA Pediatric Leadership Council commentary: Personal protective equipment during care of children with multisystem inflammatory syndrome in children (MIS-C)

Published online by Cambridge University Press:  14 June 2021

Martha L. Muller*
Affiliation:
Department of Pediatrics, University of New Mexico, Albuquerque, New Mexico
Latania K. Logan
Affiliation:
Section of Pediatric Infectious Diseases, Department of Pediatrics, Rush University Medical Center, Rush Medical College, Chicago, Illinois
Larry K. Kociolek
Affiliation:
Department of Pediatrics, Ann & Robert H. Lurie Children’s Hospital of Chicago and Northwestern University Feinberg School of Medicine Chicago, Illinois
Judith A. Guzman-Cottrill
Affiliation:
Department of Pediatrics, Oregon Health and Science University, Portland, Oregon
Allison H. Bartlett
Affiliation:
Section of Pediatric Infectious Diseases, The University of Chicago Medicine Comer Children’s Hospital, Chicago, Illinois
Joshua K. Schaffzin
Affiliation:
Division of Infectious Diseases, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio
Karen A. Ravin
Affiliation:
Division of Infectious Diseases, Nemours/Alfred I. duPont Hospital for Children, Wilmington, Delaware Department of Pediatrics, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania
Lorry G. Rubin
Affiliation:
Department of Pediatrics, Cohen Children’s Medical Center, Northwell Health, New Hyde Park, New York Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York
Jason Lake
Affiliation:
Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah
Carolyn Caughell
Affiliation:
Hospital Epidemiology and Infection Prevention, Department of Quality, University of California San Francisco Health, San Francisco, California
Lynn Ramirez-Avila
Affiliation:
Division of Pediatric Infectious Diseases and Global Health, University of California San Francisco, San Francisco, California
*
Author for correspondence: Martha L. Muller, Email: mlmuller@salud.unm.edu

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentary
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Feldstein, LR, Rose, EB, Horwitz, SM, et al. Multisystem inflammatory syndrome in US children and adolescents. N Engl J Med 2020;383:334346.CrossRefGoogle Scholar
Whittaker, E, Bamford, A, Kenny, J, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 2020;324:259269.CrossRefGoogle ScholarPubMed
Ramcharan, T, Nolan, O, Lai, CY, et al. Paediatric inflammatory multisystem syndrome: temporally associated with SARS-CoV-2 (PIMS-TS): cardiac features, management and short-term outcomes at a UK tertiary paediatric hospital. Pediatr Cardiol 2020;41:13911401.CrossRefGoogle Scholar
Godfred-Cato, S, Bryant, B, Leung, J, et al. COVID-19–associated multisystem inflammatory syndrome in children—United States, March–July 2020. MMWR 2020;69:10741080.Google ScholarPubMed
Simpson, JM, Newburger, JW. Multisystem inflammatory syndrome in children in association with COVID-19. Circulation 2020;142:437440.CrossRefGoogle ScholarPubMed
Ng, KF, Kothari, T, Bandi, S, et al. COVID-19 Multisystem inflammatory syndrome in three teenagers with confirmed SARS-CoV-2 infection. J Med Virol 2020. doi: 10.1002/jmv.26206.CrossRefGoogle Scholar
Rauf, A, Vijayan, A, John, ST, Krishnan, T, Latheef, A. Multisystem inflammatory syndrome with features of atypical Kawasaki disease during COVID-19 pandemic. Indian J Pediatr 2020;87:745747.CrossRefGoogle ScholarPubMed
Galeotti, C, Bayry, J. Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol 2020;16:413414.CrossRefGoogle ScholarPubMed
Chiotos, K Bassiri, H, Behrens, EM, et al. Multisystem inflammatory syndrome in children during the coronavirus 2019 pandemic: a case series. J Pediatric Infect Dis Soc 2020;9:393398.CrossRefGoogle ScholarPubMed
Pouletty, M Borocco, C, Ouldali, N, et al. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (KAWA-COVID-19): a multicentre cohort. Ann Rheum Dis 2020;79:9991006.CrossRefGoogle ScholarPubMed
Ebina-Shibuya, R, Namkoong, H, Shibuya, Y, Horita, N. Multisystem inflammatory syndrome in children (MIS-C) with COVID-19: insights from simultaneous familial Kawasaki disease cases. Int J Infect Dis 2020;97:371373.CrossRefGoogle Scholar
Panupattanapong, S, Brooks, EB. New spectrum of COVID-19 manifestations in children: Kawasaki-like syndrome and hyperinflammatory response. Cleveland Clin J Med 2020. doi: 10.3949/ccjm.87a.ccc039.CrossRefGoogle Scholar
Cheung, EW, Zachariah, P, Gorelik, M, et al. Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City. JAMA 2020;324:294296.CrossRefGoogle ScholarPubMed
Beeching, NJ, Fletcher, TE, Beadsworth, MBJ. COVID-19: testing times. BMJ 2020;369:m1403.CrossRefGoogle ScholarPubMed
Fang, FC, Naccache, SN, Greninger, AL. The laboratory diagnosis of COVID-19: frequently asked questions. Clin Infect Dis 2020;71:29963001.CrossRefGoogle ScholarPubMed
Greninger, AL, Gombar, S, Hogan, CA, et al. Occurrence and timing of subsequent SARS-CoV-2 RT-PCR positivity among initially negative patients. Clin Infect Dis 2021;72:323326.Google Scholar
Lynch, JB, Davitkov, P, Anderson, DV, et al. Infectious Diseases Society of America guidelines on infection prevention for healthcare personnel caring for patients with suspected or known COVID-19. Clin Infect Dis 2020. doi: 10.1093/cid/ciaa1063.CrossRefGoogle Scholar
Weber, DJ, Babcock, H, Hayden, MK, et al. Universal pandemic precautions—an idea ripe for the times. Infect Control Hosp Epidemiol 2020;41:13211322.CrossRefGoogle ScholarPubMed
Chiotos, K Hayes, M, Kimberlin, DW, et al. Multicenter interim guidance on use of antivirals for children with COVID-19/SARS-CoV-2. J Pediatr Infect Dis Soc 2021;10:3448.CrossRefGoogle Scholar
Bautista-Rodriguez, C, Sanchez-de-Toledo, J, Clark, BC, et al. Multisystem inflammatory syndrome in children: an international survey. Pediatrics 2021. doi: 10.1542/peds.2020-024554.CrossRefGoogle Scholar
Pang, J, Boshier, FAT, Alders, N, Dixon, G, Breuer, J. SARS-CoV-2 polymorphisms and multisystem inflammatory syndrome in children. Pediatrics 2020;146(6):e2020019844.CrossRefGoogle ScholarPubMed
Jiang, L, Tang, K, Levin, M, et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis 2020;20:e276e288.CrossRefGoogle ScholarPubMed
Shields, K, Atlas, K, Strohm Farber, J, Lebet, R. Multisystem inflammatory syndrome in children: a review. Am J Nurs 2021;121:2637.CrossRefGoogle ScholarPubMed
Ramaswamy, A, Brodsky, NN, Sumida, TS, et al. Postinfectious inflammatory disease in MIS-C features elevated cytotoxicity signatures and autoreactivity that correlates with severity. medRxiv 2020. doi: 10.1101/2020.12.01.20241364.CrossRefGoogle Scholar
Kwak, JH, Lee, SY, Choi, JW, Korean Society of Kawasaki Disease. Clinical features, diagnosis, and outcomes of multisystem inflammatory syndrome in children associated with coronavirus disease 2019. Clin Exp Pediatr 2021;64:6875.CrossRefGoogle Scholar
Hanson, KE, Caliendo, AM, Arias, CA, et al. The Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: molecular diagnostic testing. Clin Infect Dis 2021. doi: 10.1093/cid/ciab048.CrossRefGoogle Scholar
Belay, ED, Abrams, J, Oster, ME, et al. Trends in geographic and temporal distribution of US children with multisystem inflammatory syndrome during the COVID-19 pandemic. JAMA Pediatr 2021. doi: 10.1001/jamapediatrics.2021.0630.CrossRefGoogle Scholar
Feldstein, LR, Tenforde, MW, Friedman, KG, et al. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA 2021;325:10741087.CrossRefGoogle ScholarPubMed